×
Lucid Diagnostics Inventory 2021-2025 | LUCD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Lucid Diagnostics inventory from 2021 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
View More
Lucid Diagnostics Inventory 2021-2025 | LUCD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Lucid Diagnostics inventory from 2021 to 2025. Inventory can be defined as the total value of inventories in all stages of completion.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$188.8B
Intuitive Surgical (ISRG)
$170.7B
IDEXX Laboratories (IDXX)
$51.6B
Edwards Lifesciences (EW)
$48B
Alcon (ALC)
$40.5B
IQVIA Holdings (IQV)
$32.5B
DexCom (DXCM)
$32.3B
Mettler-Toledo (MTD)
$27.2B
STERIS (STE)
$24.8B
Waters (WAT)
$18B
SONOVA HOLDING (SONVY)
$17.3B
Hologic (HOLX)
$15.2B
Penumbra (PEN)
$10.3B
Globus Medical (GMED)
$8.4B
Sysmex ADR (SSMXY)
$8.4B
Masimo (MASI)
$8.1B
Teleflex (TFX)
$5.7B
Glaukos (GKOS)
$5.4B
TransMedics (TMDX)
$4.1B
Integer Holdings (ITGR)
$3.9B
LivaNova (LIVN)
$3.1B
Veracyte (VCYT)
$2.4B
Alphatec Holdings (ATEC)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.3B
Artivion (AORT)
$2.1B
Elekta AB (EKTAY)
$1.9B
Nihon Kohden (NHNKY)
$1.9B
Integra LifeSciences Holdings (IART)
$1.2B
Pulse Biosciences (PLSE)
$1.1B
OPKO Health (OPK)
$1.1B